TIL

Instil Bio (TIL)

About Instil Bio (TIL)

Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.

Details

Daily high

$11.62

Daily low

$11.13

Price at open

$11.27

52 Week High

$42.79

52 Week Low

$10.68

Market cap

76.4M

Dividend yield

0.00%

Volume

54,619

Avg. volume

58,777

P/E ratio

-.99

Instil Bio News